Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by inthnoon Aug 27, 2023 1:52pm
189 Views
Post# 35607284

RE:RE:Cmon Mat!(not Brad).....let’s see a nice positive update!

RE:RE:Cmon Mat!(not Brad).....let’s see a nice positive update!
Hey Cardu,,,,at least you have given yourself 30 days for your prediction to come true which is a safer bet and is possible, but then to most it would be curious as to what exactly is happy. For some it might be 5 dollars or 10 dollars, and for others it would be a positive update on a BD or pan can agreements signed all of which will affect the sp differently.... If we are holding out for the 90 days for the Pan Can it is possible for it to happen within the 90 days but was also suggested in the q2 cc that it would be q4 which gives onc a now extra 3 month leeway although I think it will most likely be sooner than later....It would be nice if the company could partner with BP but could be more of a collaboration to provide product with onc and precision going it on their own.....Now having said that onc has stated multiple times that they would partner going into a phase 3 so this would be the big catalyst for the company that shows more interest and support going into the trial....Esmo will indeed be most interesting as it is supposed to provide updates on the trials and lets hope that after that we will not have to wait for os in mbc and panc before a decision is made as that would take us into 2024. One would think that everyone really has enough information to make decisions at this point and it is all about the finer details and hopefully we will know soon as this will be needed to provide support for the trials and shareholder value.
<< Previous
Bullboard Posts
Next >>